IL-24 as A Potential Drug Target for Cancer and Autoimmune Disorders

Target Name: IL24

NCBI ID: G11009

IL-24 as A Potential Drug Target for Cancer and Autoimmune Disorders

IL-24, a cytokine that plays a crucial role in the regulation of immune responses and inflammation, has recently been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, autoimmune disorders, and chronic obstructive pulmonary disease (COPD).

IL-24 is a cytokine that is expressed in various tissues throughout the body, including the lungs, spleen, heart, kidneys, and lymphoid organs. It is a key regulator of T cell development and function, and has been shown to play a role in the regulation of immune responses, inflammation, and fibrosis.

One of the key functions of IL-24 is its ability to promote the activation and proliferation of T cells. T cells are a crucial part of the immune system, and are responsible for detecting and responding to foreign substances in the body. When T cells are activated, they undergo a process called clonal expansion, followed by differentiate into memory T cells and regulatory T cells. IL-24 has been shown to play a key role in the regulation of T cell development and function, and has been shown to promote the activation and proliferation of T cells.

IL-24 has also been shown to have a role in the regulation of inflammation. When the body is exposed to a foreign substance, such as bacteria or viruses, IL-24 is released in response to help stimulate an immune response. IL-24 has been shown to promote the production of pro-inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6. However, IL-24 has also been shown to have anti-inflammatory effects, as it can inhibit the production of pro-inflammatory cytokines.

In addition to its role in T cell development and function, IL-24 has also been shown to have a role in the regulation of fibrosis. Fibrosis is the process by which the body replaces damaged tissue with scar tissue, which can lead to a range of diseases, including cancer, heart disease, and COPD. IL-24 has been shown to promote the production of pro-inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6, which can contribute to the development and progression of fibrosis. However, IL-24 has also been shown to have anti-fibrosis effects, as it can inhibit the production of pro-inflammatory cytokines and promote the production of anti-inflammatory cytokines.

Due to its role in T cell development and function, IL-24 has recently been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, autoimmune disorders, and COPD. For example, some studies have shown that inhibiting the activity of IL-24 has the potential to treat cancer by suppressing the immune response and preventing the formation of cancerous tumors. Additionally, IL-24 has been shown to have the potential to treat autoimmune disorders, such as rheumatoid arthritis and lupus, by suppressing the production of pro-inflammatory cytokines and improving the function of immune cells.

In conclusion, IL-24 is a cytokine that plays a crucial role in the regulation of immune responses and inflammation. Its role in T cell development and function, as well as its anti-inflammatory and anti-fibrosis effects make it a promising candidate for the treatment of various diseases, including cancer, autoimmune disorders, and COPD. Further research is needed to fully understand the potential mechanisms of IL-24 and its potential as a drug target or biomarker.

Protein Name: Interleukin 24

Functions: Multifunctional cytokine mainly produced by T-cells that plays a regulatory role in immune response, tissue homeostasis, host defense, and oncogenesis (PubMed:25168428, PubMed:27687232). Possesses antiviral functions and induces the type I intereferon response during influenza infection (PubMed:27687232). Signals through two receptor complexes IL20RA/IL20RB or IL20RB/IL22RA1 (PubMed:11706020, PubMed:30111632). In turn, stimulates the JAK1-STAT3 and MAPK pathways and promotes the secretion of pro-inflammatory mediators including IL8 and MMP1 (PubMed:25168428). Intracellularly, maintains endoplasmic reticulum homeostasis by restricting the eIF2alpha-CHOP pathway-mediated stress signal (By similarity). In addition, acts as a quality control mechanism for the ubiquitin proteasome system by alerting the cell to proteasome dysfunction through activation of PKR/EIF2AK2 (By similarity)

More Common Targets